Contact lenses poised to detect cancer, treat disease and replace digital screens

Newly-published “contact lens technologies of the future” paper reviews innovative uses for disease detection and therapy, drug delivery, vision enhancement and mor

Read more

FDA approvals strengthen Octapharma USA pediatric critical care product portfolio

Octaplas™ and fibryga® receive new product labeling following FDA’s approval of BLA supplements to update therapy research; FDA expands fibryga® indication to include treatment of children under 12 years of age

Read more

Experimental antibodies for Parkinson’s, Alzheimer’s may cause harmful inflammation

Scientists find evidence that antibody-based treatments in clinical trials for neurodegenerative diseases may trigger an inflammatory response in human brain immune cells, eroding their positive effects.

Read more